| mRNA |
SNX-2112 |
GDSC1000 |
pan-cancer |
AAC |
0.0034 |
0.9 |
| mRNA |
Bicalutamide |
GDSC1000 |
pan-cancer |
AAC |
-0.0037 |
0.9 |
| mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0035 |
0.9 |
| mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |
| mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |
| mRNA |
WAY-362450 |
CTRPv2 |
pan-cancer |
AAC |
0.0039 |
0.9 |
| mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |
| mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0032 |
0.9 |
| mRNA |
spautin-1 |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |